Cited by 31Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanisms

Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system

Open access
Skripuletz, Thomas, Miller, Elvira, Grote, Lisa, Gudi, Viktoria, Pul, Refik, Voss, Elke, Škuljec, Jelena, Moharregh-Khiabani, Darius +2 more·2011·Brain, Behavior, and Immunity

Abstract

Systemic infection can influence the course in many diseases of the central nervous system (CNS) such as multiple sclerosis (MS), yet the relationship between infection outside the CNS and potential damage and/or protection within the CNS is still not understood. Activation of microglia is a characteristic feature of most CNS autoimmune disorders, including MS, and both protective and degenerative functions of microglia have been proposed. Hence, we analyzed the effects of a systemic inflammatory reaction induced by peripheral treatment with lipopolysaccharide (LPS) on microglial reaction and cuprizone induced de- and remyelination. We found that LPS administration delayed demyelination, which was linked with inhibition of microglial proliferation and reduced numbers of activated microglia. The phenotype of microglia changed as an increase of Toll-like receptor 4 was found. During remyelination, LPS treatment delayed the onset of myelin protein re-expression, but later there was a beneficial effect via an increase of proliferating oligodendrocyte precursor cells (OPC) and mature oligodendrocytes. Moreover, the expression of ciliary neurotrophic factor was increased in response to LPS, a growth factor known to mediate OPC proliferation. Additional experiments showed that the time window to induce LPS effects was limited and associated with the presence of microglia. In conclusion, LPS delayed demyelination and caused beneficial effects on remyelination via increasing the proli…

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2011.05.009

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Once demyelination is complete, the amount of activated RCA-1/Mac-3-positive microglia starts to decrease.

    “Once demyelination is complete the amount of activated RCA-1 (RCA, Ricinus communis agglutinin-1)/Mac-3-positive microglia starts to decrease (Mason et al., 2004; Skripuletz et al., 2011b).”

    From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2011b

  • After 3 weeks of cuprizone treatment, mature oligodendrocytes are almost completely depleted.

    “After 3 weeks of cuprizone treatment mature oligodendrocytes are almost completely depleted (Hesse et al., 2010; Skripuletz et al., 2011b).”

    From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2011b

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Skripuletz, T., Miller, E., Grote, L., Gudi, V., Pul, R., Voss, E., Škuljec, J., Moharregh-Khiabani, D., Trebst, C., & Stangel, M.
Affiliations
Medizinische Hochschule Hannover (DE)
Corresponding author
Stangel, Martin
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2011-11
Volume
25
Issue
8
Pages
1592-1606
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2002764553
Cited by
31
References
7
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 4 · 2015: 6 · 2014: 5 · 2013: 2 · 2012: 2
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders
Medizinischen Hochschule Hannover
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
lipopolysaccharide, demyelination, remyelination, oligodendrocyte precursor cells, microglia, TLR4, ciliary neurotrophic factor, cuprizone, multiple sclerosis, systemic infection, oligodendrocyte proliferation
MeSH terms
Animals, Axons, Cell Count, Central Nervous System, Chelating Agents, Cuprizone, Demyelinating Diseases, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Male, Mice, Inbred C57BL, Myelin Sheath, Oligodendroglia, Phagocytosis, Rats, Sprague-Dawley, Microglia, Cell Proliferation, Mice, Rats, Neural Stem Cells, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review